{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:30:59Z","timestamp":1790713859121,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS0916220"],"award-info":[{"award-number":["R01NS0916220"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS085336"],"award-info":[{"award-number":["R01NS085336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1R000138"],"award-info":[{"award-number":["TL1R000138"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002553","name":"Aid for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010079","name":"Kortney Rose Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010079","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bone.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T13:01:03Z","timestamp":1501678863000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases"],"prefix":"10.1016","volume":"109","author":[{"given":"Harry J.","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bone.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrg1178","article-title":"From developmental disorder to heritable cancer: it's all in the BMP\/TGF-beta family","volume":"4","author":"Waite","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bone.2017.08.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022269","article-title":"TGF-beta family signaling in connective tissue and skeletal diseases","author":"MacFarlane","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ejhg.2008.178","article-title":"Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements","volume":"17","author":"Bocciardi","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bone.2010.10.164","article-title":"A novel ACVR1 mutation in the glycine\/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date","volume":"48","author":"Gregson","year":"2011","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2017.08.001_bb0040","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/ajmg.a.37205","article-title":"Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): a report of two patients","volume":"167A","author":"Kaplan","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005005","article-title":"Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients","volume":"4","author":"Petrie","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jbmr.1473","article-title":"Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1","volume":"27","author":"Whyte","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0060","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0070","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.08.001_bb0075","first-page":"473","article-title":"Identify cancer driver genes through shared Mendelian disease pathogenic variatns and cancer somatic mutations","volume":"22","author":"Ma","year":"2016","journal-title":"Pac. Symp. Biocomput."},{"issue":"6","key":"10.1016\/j.bone.2017.08.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006081","article-title":"Inherited disease genetics improves the identification of cancer-associated genes","volume":"12","author":"Zhao","year":"2016","journal-title":"PLoS Genet."},{"issue":"17","key":"10.1016\/j.bone.2017.08.001_bb0085","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1158\/0008-5472.CAN-14-1298","article-title":"ACVR1 mutations in DIPG: lessons learned from FOP","volume":"74","author":"Taylor","year":"2014","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bone.2017.08.001_bb0090","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jmedgenet-2016-104076","article-title":"Novel asymptomatic CNS findings in patients with ACVR1\/ALK2 mutations causing fibrodysplasia ossificans progressiva","volume":"53","author":"Severino","year":"2016","journal-title":"J. Med. Genet."},{"issue":"12","key":"10.1016\/j.bone.2017.08.001_bb0095","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s00415-012-6562-y","article-title":"Neurological symptoms in individuals with fibrodysplasia ossificans progressiva","volume":"259","author":"Kitterman","year":"2012","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.bone.2017.08.001_bb0100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1042\/BST20160069","article-title":"Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition","volume":"44","author":"Jiramongkolchai","year":"2016","journal-title":"Biochem. Soc. Trans."},{"issue":"14","key":"10.1016\/j.bone.2017.08.001_bb0105","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.febslet.2012.02.043","article-title":"Promiscuity and specificity in BMP receptor activation","volume":"586","author":"Mueller","year":"2012","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcb.2014.12.004","article-title":"BMP signalling: agony and antagony in the family","volume":"25","author":"Brazil","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022129","article-title":"Non-Smad signaling pathways of the TGF-beta family","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bone.2017.08.001_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF02152373","article-title":"A morphogenetic matrix for differentiation of bone tissue","author":"Urist","year":"1970","journal-title":"Calcif. Tissue Res."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0006-291X(05)80208-6","article-title":"The non-osteogenic mouse pluripotent cell line, C3H10T1\/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2","volume":"172","author":"Katagiri","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6 Pt 1","key":"10.1016\/j.bone.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1083\/jcb.127.6.1755","article-title":"Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage","volume":"127","author":"Katagiri","year":"1994","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1083\/jcb.113.3.681","article-title":"Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro","volume":"113","author":"Yamaguchi","year":"1991","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0046-8177(97)90133-7","article-title":"Bone morphogenetic protein 2\/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva","volume":"28","author":"Gannon","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bone.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1196\/annals.1346.008","article-title":"Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva","volume":"1068","author":"Kaplan","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bone.2017.08.001_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM199608223350804","article-title":"Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva","volume":"335","author":"Shafritz","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s002239900693","article-title":"Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva","volume":"65","author":"Virdi","year":"1999","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.071030","article-title":"Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP)","volume":"23","author":"Billings","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0165","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/stem.1633","article-title":"Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification","volume":"32","author":"Culbert","year":"2014","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.bone.2017.08.001_bb0170","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1074\/jbc.M801681200","article-title":"Constitutively activated ALK2 and increased SMAD1\/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva","volume":"284","author":"Fukuda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.08.001_bb0175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1750-1172-8-190","article-title":"Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation","volume":"8","author":"Matsumoto","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.bone.2017.08.001_bb0180","first-page":"3462","article-title":"The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization","volume":"119","author":"Shen","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bone.2017.08.001_bb0185","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.091110","article-title":"ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation","volume":"25","author":"van Dinther","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"29","key":"10.1016\/j.bone.2017.08.001_bb0190","doi-asserted-by":"crossref","first-page":"22542","DOI":"10.1074\/jbc.M109.094557","article-title":"Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva","volume":"285","author":"Song","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bone.2017.08.001_bb0195","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/jbmr.1637","article-title":"An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva","volume":"27","author":"Chakkalakal","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"366","key":"10.1016\/j.bone.2017.08.001_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1090","article-title":"Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification","volume":"8","author":"Dey","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"303","key":"10.1016\/j.bone.2017.08.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2017.08.001_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/BLO.0b013e318126c049","article-title":"Functional modeling of the ACVR1 (R206H) mutation in FOP","volume":"462","author":"Groppe","year":"2007","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"44","key":"10.1016\/j.bone.2017.08.001_bb0215","doi-asserted-by":"crossref","first-page":"36990","DOI":"10.1074\/jbc.M112.365932","article-title":"Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva","volume":"287","author":"Chaikuad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.08.001_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12964-015-0104-z","article-title":"Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B","volume":"13","author":"Olsen","year":"2015","journal-title":"Cell Commun. Signal"},{"issue":"50","key":"10.1016\/j.bone.2017.08.001_bb0225","doi-asserted-by":"crossref","first-page":"15438","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","volume":"112","author":"Hino","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2017.08.001_bb0230","article-title":"Scleraxis-lineage cells contribute to ectopic bone formation in muscle and tendon","author":"Agarwal","year":"2016","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.bone.2017.08.001_bb0235","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0240","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in Fibrodysplasia Ossificans Progressiva (FOP): a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1634\/stemcells.2008-0576","article-title":"Dysregulation of local stem\/progenitor cells as a common cellular mechanism for heterotopic ossification","volume":"27","author":"Kan","year":"2009","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.bone.2017.08.001_bb0250","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/jcb.23259","article-title":"Substance P signaling mediates BMP-dependent heterotopic ossification","volume":"112","author":"Kan","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11914-015-0258-z","article-title":"The immunological contribution to heterotopic ossification disorders","volume":"13","author":"Convente","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"issue":"8","key":"10.1016\/j.bone.2017.08.001_bb0260","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/hupa.2001.26464","article-title":"Mast cell involvement in fibrodysplasia ossificans progressiva","volume":"32","author":"Gannon","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bone.2017.08.001_bb0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-199801000-00005","article-title":"Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva","volume":"346","author":"Gannon","year":"1998","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"12","key":"10.1016\/j.bone.2017.08.001_bb0270","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic [corrected] ossification","volume":"14","author":"Yu","year":"2008","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nchembio.2007.54","article-title":"Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism","volume":"4","author":"Yu","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"10.1016\/j.bone.2017.08.001_bb0280","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.bmcl.2013.03.113","volume":"23","author":"Engers","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/cb9002865","article-title":"In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors","volume":"5","author":"Hao","year":"2010","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.bone.2017.08.001_bb0290","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/cb300655w","article-title":"Development of an ALK2-biased BMP type I receptor kinase inhibitor","volume":"8","author":"Mohedas","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"19","key":"10.1016\/j.bone.2017.08.001_bb0295","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1021\/jm501177w","article-title":"Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants","volume":"57","author":"Mohedas","year":"2014","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bone.2017.08.001_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062721","article-title":"A new class of small molecule inhibitor of BMP signaling","volume":"8","author":"Sanvitale","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.bone.2017.08.001_bb0305","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2016-09-740092","article-title":"Momelotinib inhibits ACVR1\/ALK2, decreases hepcidin production and ameliorates anemia of chronic disease in rodents","volume":"129","author":"Asshoff","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bone.2017.08.001_bb0310","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bbagrm.2013.08.002","article-title":"Serum regulation of Id1 expression by a BMP pathway and BMP responsive element","volume":"1829","author":"Lewis","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bone.2017.08.001_bb0315","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/neuonc\/nou330","article-title":"Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma","volume":"17","author":"Truffaux","year":"2015","journal-title":"Neuro-Oncology"},{"issue":"7","key":"10.1016\/j.bone.2017.08.001_bb0320","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/gt.2011.152","article-title":"Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting","volume":"19","author":"Kaplan","year":"2012","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.bone.2017.08.001_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069096","article-title":"Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bone.2017.08.001_bb0330","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) mutation","volume":"31","author":"Chakkalakal","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2017.08.001_bb0335","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nm.2334","article-title":"Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists","volume":"17","author":"Shimono","year":"2011","journal-title":"Nat. Med."},{"issue":"7384","key":"10.1016\/j.bone.2017.08.001_bb0340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0345","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0350","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0355","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-015-1405-4","article-title":"Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers","volume":"129","author":"Korshunov","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-016-0353-0","article-title":"Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma","volume":"4","author":"Ryall","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0365","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.bone.2017.08.001_bb0370","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev."},{"issue":"6134","key":"10.1016\/j.bone.2017.08.001_bb0375","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.bone.2017.08.001_bb0380","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.3716","article-title":"Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma","volume":"20","author":"Hashizume","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.08.001_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","author":"Mohammad","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2017.08.001_bb0390","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","author":"Piunti","year":"2017","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bone.2017.08.001_bb0395","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bone.2017.08.001_bb0400","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","article-title":"Disrupting NOTCH slows diffuse intrinsic pontine glioma growth, enhances radiation sensitivity, and shows combinatorial efficacy with bromodomain inhibition","volume":"74","author":"Taylor","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bone.2017.08.001_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"issue":"6216","key":"10.1016\/j.bone.2017.08.001_bb0410","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1253799","article-title":"Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation","volume":"346","author":"Funato","year":"2014","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.bone.2017.08.001_bb0415","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bpa.12043","article-title":"PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma","volume":"23","author":"Phillips","year":"2013","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bone.2017.08.001_bb0425","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bone.2017.08.001_bb0430","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ng.2995","article-title":"Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.08.001_bb0435","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bone.2017.08.001_bb0440","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.cellsig.2011.06.019","article-title":"The specificities of small molecule inhibitors of the TGFss and BMP pathways","volume":"23","author":"Vogt","year":"2011","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.bone.2017.08.001_bb0445","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/0008-5472.CAN-05-4505","article-title":"Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies","volume":"66","author":"Sasai","year":"2006","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118926","article-title":"A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent","volume":"10","author":"Halvorson","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0455","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neo.2015.12.002","article-title":"A novel mouse model of diffuse intrinsic pontine glioma initiated in Pax3-expressing cells","volume":"18","author":"Misuraca","year":"2016","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0460","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nn.4493","article-title":"Identification of diverse astrocyte populations and their malignant analogs","volume":"20","author":"John Lin","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"7483","key":"10.1016\/j.bone.2017.08.001_bb0465","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature12983","article-title":"Interneuron cell types are fit to function","volume":"505","author":"Kepecs","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0470","doi-asserted-by":"crossref","first-page":"a020453","DOI":"10.1101\/cshperspect.a020453","article-title":"Oligodendrocyte development and plasticity","volume":"8","author":"Bergles","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0475","doi-asserted-by":"crossref","first-page":"a020362","DOI":"10.1101\/cshperspect.a020362","article-title":"Astrocyte development and heterogeneity","volume":"7","author":"Bayraktar","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.bone.2017.08.001_bb0480","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008359","article-title":"Molecular control of neurogenesis: a view from the mammalian cerebral cortex","volume":"4","author":"Martynoga","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"10.1016\/j.bone.2017.08.001_bb0485","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/dneu.22022","article-title":"The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation","volume":"72","author":"Bond","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.bone.2017.08.001_bb0490","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.vh.2015.05.005","article-title":"Bone morphogenetic proteins: inhibitors of myelination in development and disease","volume":"99","author":"Grinspan","year":"2015","journal-title":"Vitam. Horm."},{"issue":"6","key":"10.1016\/j.bone.2017.08.001_bb0495","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1515\/hsz-2012-0310","article-title":"The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway","volume":"394","author":"Katagiri","year":"2013","journal-title":"Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bone.2017.08.001_bb0500","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000017429","article-title":"Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate","volume":"22","author":"Mehler","year":"2000","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.bone.2017.08.001_bb0505","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pneurobio.2013.07.002","article-title":"BMP-Smad 1\/5\/8 signalling in the development of the nervous system","volume":"109","author":"Hegarty","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"7120","key":"10.1016\/j.bone.2017.08.001_bb0510","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature05349","article-title":"Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells","volume":"444","author":"Piccirillo","year":"2006","journal-title":"Nature"},{"issue":"Pt 7","key":"10.1016\/j.bone.2017.08.001_bb0515","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/brain\/awq128","article-title":"Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells","volume":"133","author":"Chirasani","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0520","first-page":"77","article-title":"Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells","volume":"26","author":"Zhou","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0525","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1541-7786.MCR-13-0349","article-title":"BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells","volume":"12","author":"Srikanth","year":"2014","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0530","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2007.12.005","article-title":"Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells","volume":"13","author":"Lee","year":"2008","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.bone.2017.08.001_bb0535","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1101\/gad.894701","article-title":"Sequential actions of BMP receptors control neural precursor cell production and fate","volume":"15","author":"Panchision","year":"2001","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.bone.2017.08.001_bb0540","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0545","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cne.23690","article-title":"Postnatal growth of the human pons: a morphometric and immunohistochemical analysis","volume":"523","author":"Tate","year":"2015","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bone.2017.08.001_bb0550","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1038\/ncomms11628","article-title":"Identification of proliferative progenitors associated with prominent postnatal growth of the pons","volume":"7","author":"Lindquist","year":"2016","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bone.2017.08.001_bb0555","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0b013e318294e817","article-title":"Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas","volume":"37","author":"Ballester","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bone.2017.08.001_bb0560","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/now299","article-title":"The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas","author":"Anderson","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0565","doi-asserted-by":"crossref","first-page":"a018887","DOI":"10.1101\/cshperspect.a018887","article-title":"Control of adult neurogenesis by short-range morphogenic-signaling molecules","volume":"8","author":"Choe","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0570","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jnr.20856","article-title":"Genetically modified bone morphogenetic protein signalling alters traumatic brain injury-induced gene expression responses in the adult mouse","volume":"84","author":"Israelsson","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.bone.2017.08.001_bb0575","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s00415-012-6563-x","article-title":"CNS demyelination in fibrodysplasia ossificans progressiva","volume":"259","author":"Kan","year":"2012","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0580","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0012-1606(02)00037-4","article-title":"Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment","volume":"255","author":"Gomes","year":"2003","journal-title":"Dev. Biol."},{"issue":"12","key":"10.1016\/j.bone.2017.08.001_bb0585","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1242\/dev.106492","article-title":"Combinatorial actions of Tgfbeta and Activin ligands promote oligodendrocyte development and CNS myelination","volume":"141","author":"Dutta","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bone.2017.08.001_bb0590","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ncomms1817","article-title":"Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors","volume":"3","author":"Cambray","year":"2012","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bone.2017.08.001_bb0595","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0600","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0042-105292","article-title":"No significant cytotoxic effect of the EZH2 inhibitor Tazemetostat (EPZ-6438) on pediatric glioma cells with wildtype histone 3 or mutated histone 3.3","volume":"228","author":"Wiese","year":"2016","journal-title":"Klin. Padiatr."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0605","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/carcin\/bgn274","article-title":"Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2","volume":"30","author":"Gordon","year":"2009","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0610","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2009.02.046","article-title":"Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells","volume":"281","author":"Deng","year":"2009","journal-title":"Cancer Lett."},{"issue":"32","key":"10.1016\/j.bone.2017.08.001_bb0615","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.1073\/pnas.1510837112","article-title":"Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bone.2017.08.001_bb0620","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tranon.2016.12.008","article-title":"Dual inhibition of PI3K\/AKT and MEK\/ERK pathways induces synergistic antitumor effects in diffuse intrinsic pontine glioma cells","volume":"10","author":"Wu","year":"2017","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.bone.2017.08.001_bb0625","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/147323001003800416","article-title":"Expression of activin A and follistatin in glioblastoma and their effects on U87 in vitro","volume":"38","author":"Zhang","year":"2010","journal-title":"J. Int. Med. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.08.001_bb0630","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bone.2017.08.001_bb0635","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00401-014-1272-4","article-title":"Human pontine glioma cells can induce murine tumors","volume":"127","author":"Caretti","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"27","key":"10.1016\/j.bone.2017.08.001_bb0640","doi-asserted-by":"crossref","first-page":"42837","DOI":"10.18632\/oncotarget.10034","article-title":"Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report","volume":"7","author":"Nazarian","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0645","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/0023210-200923010-00003","article-title":"Getting into the brain: approaches to enhance brain drug delivery","volume":"23","author":"Patel","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bone.2017.08.001_bb0650","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ddtec.2016.07.007","article-title":"Ultrasound-mediated drug delivery to the brain: principles, progress and prospects","volume":"20","author":"Dasgupta","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bone.2017.08.001_bb0655","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2016.07.005","article-title":"Liposome technologies and drug delivery to the CNS","volume":"20","author":"Rip","year":"2016","journal-title":"Drug Discov. Today Technol."},{"issue":"1","key":"10.1016\/j.bone.2017.08.001_bb0660","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1570159X14666160614093615","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma treatment","volume":"15","author":"Zhou","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bone.2017.08.001_bb0665","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1038\/ncomms8033","article-title":"Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes","volume":"6","author":"Melamed","year":"2015","journal-title":"Nat. Commun."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821730265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821730265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:12:59Z","timestamp":1778940779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821730265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":133,"alternative-id":["S875632821730265X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.08.001","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}